DAA281 |
coiled-coil domain containing 3 |
Molecular |
kidney |
Human |
CCDC3 |
19.0% Increase Gene Expression Level |
|
DAA282 |
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 5 |
Molecular |
kidney |
Human |
SERPINA5 |
11.0% Decrease Gene Expression Level |
|
DAA283 |
lactotransferrin |
Molecular |
kidney |
Human |
LTF |
115.0% Increase Gene Expression Level |
|
DAA284 |
immunoglobulin lambda variable 4-3 |
Molecular |
kidney |
Human |
IGLV4-3 |
41.0% Increase Gene Expression Level |
|
DAA285 |
immunoglobulin kappa variable 1-5 |
Molecular |
kidney |
Human |
IGKV1-5 |
35.0% Increase Gene Expression Level |
|
DAA286 |
StAR-related lipid transfer (START) domain containing 8 |
Molecular |
kidney |
Human |
STARD8 |
14.0% Decrease Gene Expression Level |
|
DAA287 |
creatine kinase, brain |
Molecular |
kidney |
Human |
CKB |
10.0% Decrease Gene Expression Level |
|
DAA288 |
complement component 1, r subcomponent |
Molecular |
kidney |
Human |
C1R |
21.0% Increase Gene Expression Level |
|
DAA289 |
brain protein 44-like |
Molecular |
kidney |
Human |
BRP44L |
9.0% Decrease Gene Expression Level |
|
DAA290 |
lysozyme (renal amyloidosis) |
Molecular |
kidney |
Human |
LYZ |
57.0% Increase Gene Expression Level |
|
DAA291 |
chromosome 1 open reading frame 162 |
Molecular |
kidney |
Human |
C1orf162 |
37.0% Increase Gene Expression Level |
|